Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

As previously reported, Craig-Hallum initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Interest in weight loss ...

LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...

LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

"Second quarter revenue results were exceptional, reflecting strong sales of the MindBody GLP-1 System we launched in October in the United States along with outstanding execution by our team to ...

LifeVantage shares soared Wednesday after the company said its financial outlook for 2025 is brighter than previously expected. The health and nutrition company's stock rose 30% to $21.40 in morning ...

LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

Aston Martin's new Formula 1 boss Andy Cowell will take on the role of team principal in addition to his position as chief executive officer. Colapinto joins Alpine as reserve after Williams ...

GLP-1 drugs spiked in popularity and price over the past few years, leaving the door open for illegal pharmacies to try and ...

From addiction and heart disease to liver disease and sleep apnea, it seems like there's nothing that these new weight-loss ...